Textbook of Psychiatric Epidemiology 3rd Edition

The new edition of this critically praised textbook continues to provide the most comprehensive overview of the concepts, methods, and research advances in the field; particularly the application of molecular genomics and of neuroimaging. It has been revised and enhanced to capitalize on the strengths of the first and second editions while keeping it up-to-date with the field of psychiatry and epidemiology. This comprehensive publication now includes chapters on experimental epidemiology, gene-environment interactions, the use of case registries, eating disorders, suicide, childhood disorders and immigrant populations, and the epidemiology of a number of childhood disorders.

As in the first and second editions, the objective is to provide a comprehensive, easy to understand overview of research methods for the non-specialist. The book is ideal for students of psychiatric epidemiology, psychiatric residents, general psychiatrists, and other mental health professionals.

The book features a new editor, Peter Jones, from the University of Cambridge, who joins the successful US team of Ming Tsuang and Mauricio Tohen.

Contents

1 Introduction to epidemiologic research methods (Glyn Lewis).

• 1.1 What is epidemiology?
• 1.2 Causation in medicine.
• 1.3 Causal inference.
• 1.4 The future for psychiatric epidemiology.

2 Analysis of categorical data: The odds ratio as a measure of association and beyond (Garrett M. Fitzmaurice and Caitlin Ravichandran).

• 2.1 Introduction.
• 2.2 Inference for a single proportion.
• 2.3 Analysis of 2 x 2 contingency tables.
• 2.4 Analysis of sets of 2 x 2 contingency tables.
• 2.5 Logistic regression.
• 2.6 Advanced topics.
• 2.7 Concluding remarks.
• 2.8 Further reading.

3 Genetic epidemiology (Stephen V. Faraone, Stephen J. Glatt and Ming T. Tsuang).

• 3.1 Introduction.
• 3.2 The chain of psychiatric genetic research.
• 3.3 Psychiatric genetics and psychiatric epidemiology.

4 Examining gene–environment interplay in psychiatric disorders (Judith Allardyce and Jim van Os).

• 4.1 Introduction.
• 4.2 The process of genetic epidemiology.
• 4.3 Gene–environment interplay takes different forms.
• 4.4 Gene–environment correlation.
• 4.5 Gene–environment interaction.
• 4.6 Measurement of genotype, environmental exposure and pathological phenotype.
• 4.7 Models of GxE.
• 4.8 Which scale should we use to measure GxE?
• 4.9 Study designs for the detection of GxE.
• 4.10 Threats to the validity of epidemiological GxE studies.
• 4.11 Epigenetic mechanisms.

5 Reliability (Patrick E. Shrout).

• 5.1 Introduction.
• 5.2 The reliability coefficient.
• 5.3 Designs for estimating reliability.
• 5.4 Statistical remedies for low reliability.
• 5.5 Reliability theory and binary judgements.
• 5.6 Reliability statistics: General.
• 5.7 Other reliability statistics.
• 5.8 Summary and conclusions.

6 Moderators and mediators: Towards the genetic and environmental bases of psychiatric disorders (Helena Chmura Kraemer).

• 6.1 Introduction.
• 6.2 Current methodological barriers.
• 6.3 Moderation, mediation and other ways in which risk factors 'work together'.
• 6.4 Extensions.
• 6.5 Beyond moderators and mediators.

7 Validity: Definitions and applications to psychiatric research (Jill M. Goldstein, Sara Cherkerzian and John C. Simpson).

• 7.1 Introduction.
• 7.2 Validity of a construct.
• 7.3 Validity of the relationships between variables.
• 7.4 Summary.

8 Use of register data for psychiatric epidemiology in the Nordic countries (Jouko Miettunen, Jaana Suvisaari, Jari Haukka and Matti Isohanni).

• 8.1 Introduction.
• 8.2 Registers for use in psychiatric research.
• 8.3 Register research in Denmark.
• 8.4 Register research in Finland.
• 8.5 Register research in Norway.
• 8.6 Register research in Sweden.
• 8.7 Discussion.

9 An introduction to mental health services research (Anna Fernandez, Alejandra Pinto-Meza, Antoni Serrano-Blanco, Jordi Alonso and Josep Maria Haro).

• 9.1 Introduction.
• 9.2 What is mental health services research?
• 9.3 A framework for mental health services research.
• 9.4 Key concepts in mental health services research.
• 9.5 Examples of mental health services research studies.
• 9.6 Conclusion.

10 The pharmacoepidemiology of psychiatric medications (Philip S. Wang, Alan M. Brookhart, Christine Ulbricht and Sebastian Schneeweiss).

• 10.1 Introduction.
• 10.2 Overview of psychopharmacoepidemiology.
• 10.3 Sources of data.
• 10.4 Examples of recent psychopharmacoepidemiologic studies.
• 10.5 Conclusions.

11 Peering into the future of psychiatric epidemiology (Michaeline Bresnahan, Ezra Susser, Dana March and Bruce Link).

• 11.1 Introduction.
• 11.2 Levels of causation: A historical overview.
• 11.3 Levels of causation.
• 11.4 Causation over (life) time.
• 11.5 Examples.
• 11.6 Framing the future.

12 Studying the natural history of psychopathology (William W. Eaton).

• 12.1 Introduction.
• 12.2 Onset.
• 12.3 Course.
• 12.4 Outcome.
• 12.5 Methodological concepts for studying the natural history of psychopathology.
• 12.6 Conclusion.

13 Symptom scales and diagnostic schedules in adult psychiatry (Jane M. Murphy).

• 13.1 Introduction.
• 13.2 North American instruments for epidemiological research.
• 13.3 North American instruments for psychiatric services and primary care.
• 13.4 European instruments for psychiatric services and primary care.
• 13.5 European instruments for epidemiological research.
• 13.6 Summary.

14 The National Comorbidity Survey (NCS) and its extensions (Ronald C. Kessler).

• 14.1 Introduction.
• 14.2 The baseline NCS.
• 14.3 The NCS follow-up survey (NCS-2).
• 14.4 The NCS replication survey (NCS-R).
• 14.5 The NCS-R adolescent supplement (NCS-A).
• 14.6 The WHO WMH Surveys.
• 14.7 Overview.

15 Experimental epidemiology (John R. Geddes).

• 15.1 Introduction.
• 15.2 Limitations of non-randomised evidence.
• 15.3 RCTs: The translation of the experimental design into the real world.
• 15.4 Importance and control of systematic error or bias.
• 15.5 Importance and control of random error and noise.
• 15.6 Reporting the results of clinical trials—the CONSORT statement.
• 15.7 Different clinical questions will prioritise control of different threats to validity and confidence.
• 15.8 The classification of RCTs.
• 15.9 Effectiveness trials in schizophrenia.
• 15.10 Department of Veterans Affairs co-operative study on the cost-effectiveness of Olanzapine (Rosenheck).
• 15.11 The clinical antipsychotic trials of intervention effectiveness (CATIE) study.
• 15.12 Cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1).
• 15.13 European first-episode schizophrenia trial (EUFEST).
• 15.14 The size and cost of experimental studies in psychiatry.
• 15.15 Clinical trials in the future.

16 Epidemiology of Schizophrenia (William W. Eaton, Chuan-Yu Chen and Evelyn J. Bromet).

• 16.1 Introduction.
• 16.2 Methods.
• 16.3 The burden of schizophrenia.
• 16.4 Natural history.
• 16.5 Demographic correlates.
• 16.6 Social risk factors.
• 16.7 Biological risk factors.
• 16.8 Prevention.
• 16.9 Discussion.

17 Epidemiology of depressive disorders (Deborah S. Hasin, Miriam C. Fenton and Myrna M. Weissman).

• 17.1 Introduction.
• 17.2 Major depression.
• 17.3 Dysthymia.
• 17.4 Summary.

18 Epidemiology of anxiety disorders (Ewald Horwath, Felicia Gould and Myrna M. Weissman).

• 18.1 Introduction.
• 18.2 Anxiety disorders.
• 18.3 Panic disorder.
• 18.4 Agoraphobia.
• 18.5 Social phobia.
• 18.6 Generalised anxiety disorder.
• 18.7 Obsessive–compulsive disorder.
• 18.8 Anxiety and affective disorders and mass disasters.
• 18.9 Future developments.

19 Epidemiology of bipolar disorder in adults and children (Kathleen R. Merikangas and Mauricio Tohen).

• 19.1 Introduction.
• 19.2 Epidemiology of bipolar disorder.
• 19.3 Patterns of comorbidity of bipolar disorder.
• 19.4 Risk Factors.
• 19.5 Future directions.
• 19.6 Summary.

20 Epidemiology of eating disorders (Tracey D. Wade, Anna Keski-Rahkonen and James I. Hudson).

• 20.1 Introduction.
• 20.2 Case definition.
• 20.3 Major prevalence studies.
• 20.4 Incidence studies.
• 20.5 Comorbidity.
• 20.6 Mortality from eating disorders.
• 20.7 Risk factors.
• 20.8 Future directions.

21 Epidemiology of alcohol use, abuse and dependence (Deborah A. Dawson, Ralph W. Hingson and Bridget F. Grant).

• 21.1 Introduction.
• 21.2 Population estimates of per capita consumption.
• 21.3 Survey-based estimates of the prevalence of drinking.
• 21.4 Alcohol-related mortality and morbidity.
• 21.5 Alcohol and injury.
• 21.6 Alcohol and chronic disease.
• 21.7 Diagnostic classification of alcohol use disorders.
• 21.8 Population estimates, prevalence, incidence and natural course of alcohol use disorders.
• 21.9 Comorbidity of DSM-IV alcohol use disorders and other psychiatric disorders.
• 21.10 Summary.

22 Epidemiology of illicit drug use disorders (Wilson M. Compton, Marsha F. Lopez, Kevin P. Conway and Yonette F. Thomas).

• 22.1 Introduction.
• 22.2 Drug consumption.
• 22.3 Definitions.
• 22.4 Rates of DSM-IV abuse and dependence.
• 22.5 Global rates of drug use disorders.
• 22.6 Comorbidities with psychiatric conditions.
• 22.7 Genetic epidemiology.
• 22.8 Future opportunities.
• 22.9 Conclusions.
• 22.10 Disclaimer.

23 The epidemiology of personality disorders: Findings, methods and concepts (Michael J. Lyons, Beth A. Jerskey and Margo R. Genderson).

• 23.1 Introduction.
• 23.2 Substantive findings.
• 23.3 Course, prognosis and developmental issues.
• 23.4 Treated prevalence.
• 23.5 Prevalence of specific personality disorders.
• 23.6 Antisocial personality disorder.
• 23.7 Conceptual issues.
• 23.8 Models of personality disorder.
• 23.9 Methodological issues.
• 23.10 Future directions.

24 The epidemiology of depression and anxiety in children and adolescents (Kathleen Ries Merikangas and Erin F. Nakamura).

• 24.1 Introduction.
• 24.2 Magnitude of depression and anxiety in children and adolescents.
• 24.3 Correlates and risk factors.
• 24.4 Service patterns and impact.
• 24.5 Summary.

25 Epidemiology of attention deficit hyperactivity disorder (Stephen V. Faraone).

• 25.1 Introduction.
• 25.2 Prevalence of ADHD.
• 25.3 Pharmacoeconomics of ADHD.
• 25.4 Comorbid psychiatric disorders.
• 25.5 Demographic risk factors.
• 25.6 Genetic risk factors.
• 25.7 Environmental risk factors for ADHD.
• 25.8 Summary and conclusions.
• 25.9 Future directions.

26 The epidemiology of autism (Gregory S. Liptak).

• 26.1 Introduction.
• 26.2 Background.
• 26.3 Definition and diagnosis.
• 26.4 Natural history.
• 26.5 Prevalence.
• 26.6 Risk factors.
• 26.7 Genetic factors.
• 26.8 Public health impact.
• 26.9 Associations and causal factors.
• 26.10 Future directions.
• 26.11 Summary.

27 Mental illness, women, mothers and their children (Kathryn M. Abel and Vera A. Morgan).

• 27.1 Introduction.
• 27.2 The epidemiology of mental illness in women of reproductive age.
• 27.3 Fertility and fecundity in women with mental illness.
• 27.4 Maternal mental illness at the time of conception and during pregnancy.
• 27.5 Gene–environment interactions and offspring outcomes.
• 27.6 Obstetric complications and risk of adult onset mental disorder in offspring.
• 27.7 Parental condition.
• 27.8 Motherhood and perinatal mental illness.
• 27.9 Designing studies examining the relationship between maternal mental illness and outcomes for their children.
• 27.10 Conclusions.

28 Epidemiology of suicide and attempted suicide(Dianne Currier and Maria A. Oquendo).

• 28.1 Introduction.
• 28.2 Definitions.
• 28.3 Prevalence of suicide and attempted suicide.
• 28.4 Risk factors for suicide and attempted suicide.
• 28.5 Protective factors.
• 28.6 Conclusions.

29 Epidemiology and geriatric psychiatry (Celia F. Hybels and Dan G. Blazer).

• 29.1 Introduction.
• 29.2 Issues of case identification.
• 29.3 The distribution of cases.
• 29.4 Aetiological studies.
• 29.5 Outcome studies.
• 29.6 Historical trends in the epidemiology of psychiatric disorders in late life.
• 29.7 Use of health care services.

30 Recent epidemiological studies of psychiatric disorders in Japan (Masayoshi Kawai, Kenji J. Tsuchiya and Nori Takei).

• 30.1 Introduction.
• 30.2 Schizophrenia.
• 30.3 Affective disorders.
• 30.4 Autism and autism spectrum disorder.
• 30.5 Summary.

31 Epidemiology of migration and serious mental illness: The example of migrants to Europe (Monica Charalambides, Craig Morgan and Robin M. Murray).

• 31.1 Introduction.
• 31.2 Defining the constructs.
• 31.3 High rates of psychosis in migrants: A genuine finding or methodological artefact?
• 31.4 Possible explanations.
• 31.5 Biological considerations.
• 31.6 Cannabis use.
• 31.7 Adverse social experiences.
• 31.8 Mechanisms.
• 31.9 Implications.

32 Epidemiology of migration substance use disorder in Latin American populations and migration to the United States (Maria Elena Medina-Mora, Guilherme Borges, Tania Real and Jorge Villatoro).

• 32.1 Introduction.
• 32.2 Definitions: What do we understand by migration?
• 32.3 Countries of origin: Social, political and other reasons that trigger migration.
• 32.4 Living conditions of migrants in the United States.
• 32.5 Alcohol and drug use in countries of origin and receiving communities.
• 32.6 Dependence and treatment rates.
• 32.7 The process of migrating.
• 32.8 Migration, substance use and access to services.
• 32.9 Returning migrants and families left behind.
• 32.10 Conclusions.

33 Early detection and intervention as approaches for preventing schizophrenia (Ming T. Tsuang, William S. Stone, Margo Genderson and Michael Lyons).

• 33.1 Introduction.
• 33.2 Modelling genetic and phenotypic heterogeneity.
• 33.3 Defining a syndrome of liability using cognitive and clinical characteristics of relatives.
• 33.4 Gene-based vs. genome-based research.
• 33.5 Future directions.
• 33.6 Clinical implications.

Acknowledgements.

References.

Index.

About the Author

Dr. Ming Tsuang is Behavioral Genomics Endowed Chair and University Professor, University of California and Distinguished Professor of Psychiatry and Director, Center for Behavioral Genomics, Department of Psychiatry, University of California, San Diego. He also directs the Harvard Institute of Psychiatric Epidemiology and Genetics. He was Stanley Cobb Professor of Psychiatry and Chairman, Department of Psychiatry, Harvard Medical School at Massachusetts Mental Health Center, where he served as superintendent and president of Massachusetts Mental Health Institute of Psychiatry. He received his M.D. degree from National Taiwan University and his Ph.D. in Psychiatric Genetics and Doctor of Science in Genetics Epidemiology from the University of London. He has been recognized worldwide for his research in schizophrenia, manic-depressive illness and substance abuse.

He is a member of the Institute of Medicine, National Academy of Sciences, and served on the National Advisory Mental Health Council, U.S. Department of Health and Human Services. He has been elected Fellow of the American Psychiatric Association, American College of Psychiatrists, and British Royal Society of Psychiatrists, Fellow and former President of the American Psychopathological Association. He is a Council Member of the Taiwan National Health Research Institute, and Academician, Academia Sinica of Taiwan, the highest academic institution in Taiwan. He is currently the President of the International Society of Psychiatric Genetics.

Dr. Tsuang is the recipient of a myriad of awards for his work, among them: the Rema Lapouse Award for Mental Health Epidemiology, the American Public Health Association; the Stanley Dean Award for Research in Schizophrenia, the American College of Psychiatrists; the National Institute of Mental Health Merit Award; the Noyes Award for Research in Schizophrenia; the National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award; and the Paul H. Hoch Award, the American Psychopathological Association. Dr. Tsuang also received the Lifetime Achievement Award from the International Society of Psychiatric Genetics, the Taiwanese-American Award for Achievement in Science and Engineering, the Gold Medal Award from the Society of Biological Psychiatry for pioneering contributions in the field of biological psychiatry, and the Award for Research in Psychiatry, the American Psychiatric Association.

He has authored or co-authored over 600 publications, including peer review journal papers, book chapters and books in the areas of psychiatric epidemiology and genetics, including major psychoses and substance abuse and spiritual health. In addition to serving on many editorial boards of scientific journals, he is currently the Senior Editor for Neuropsychiatric Genetics, a section of the American Journal of Medical Genetics.

Dr. Mauricio Tohen obtained his MD degree from the National University of Mexico. He completed a residency in Psychiatry at the University of Toronto and a Fellowship in Psychopharmacology at McLean Hospital, Harvard Medical School. He obtained his doctorate in Epidemiology from the Harvard School of Public Health and an MBA from the University of Indiana. From 1988 to 1997 he was the clinical Director of the Bipolar and Psychotic Disorders Program at McLean Hospital. From 1997 to 2008 he worked at Lilly Research Laboratories in Indianapolis, Indiana where he reached the most senior scientific rank of Distinguished Lilly Scholar. In 2009 he was appointed to the Krus endowed chair in Psychiatry at the University of Texas Health Science Centre at San Antonio. His research has focused on the clinical epidemiology and psychopharmacological treatments of bipolar disorder. Professor Tohen has over 200 original publications and over 500 book chapters and scientific abstracts. He has co-edited Mood Disorders Across the Lifespan and Bipolar Psychopharmacology, and has also edited Comorbidity in Affective Disorders.

Professor Peter Jones is Head of the Department of Psychiatry at the University of Cambridge. His particular clinical interest is in psychotic illness and asking questions about causes and treatment. His research concerns lifecourse influences on adult mental health and illness, and the interface between population-based and biological investigation and explanations. He is a member of the Wellcome Trust Clinical Epidemiology Research Board and the HTA Commissioning Board.

Book Details

• Hardcover: 660 pages
• Publisher: Wiley; 3 edition (June 15, 2011)
• Language: English
• ISBN-10: 047069467X
• ISBN-13: 978-0470694671
• Product Dimensions: 7.7 x 1.5 x 9.9 inches

List Price: $250.00 

 

Shortell & Kaluzny's Healthcare Management: Organization Design & Behavior 6th Edition

Completely updated to address the challenges faced by modern health care organizations, the sixth edition of Shortell and Kaluzny's Healthcare Management: Organization Design and Behavior offers a more global perspective on how the United States and other countries address issues of health and health care. Written by internationally recognized and respected experts in the field, the new edition continues to bring a systemic understanding of organizational principles, practices, and insight to the management of health services organizations. Based on state-of-the-art organizational theory and research, the text emphasizes application and challenges you to provide a solution or a philosophical position. Coverage includes topics ranging from pay for performance and information technology to ethics and medical tourism and expands upon a major theme of the fifth edition: health care leaders must effectively design and manage health care organizations while simultaneously influencing and adapting to changes in environmental context.

Contents

PART I: INTRODUCTION.

• 1. The Management Challenge of Delivering Value in Health Care: Global and U.S. Perspectives.
• 2. Leadership and Management: A Framework for Action.

PART II: MICRO PERSPECTIVES.

• 3. Organization Design and Coordination.
• 4. Motivating People.
• 5. Teams and Team Effectiveness in Health Services Organizations.
• 6. Communication.
• 7. Power, Politics, and Conflict Management.
• 8. Complexity, Learning, and Innovation.
• 9. Improving Quality in Health Care Organizations.

PART III: MACRO PERSPECTIVES.

• 10. Strategic Thinking and Achieving Competitive Advantage.
• 11. Managing Strategic Alliances.
• 12. Health Policy and Regulation.
• 13. Health Information Systems and Strategy.
• 14. Consumerism and Ethics.
• 15. Globalization and Health: The World is Flattening.

Key Features

• Written by internationally recognized and respected experts in the field.
• "In Practice" feature presents a practical situation facing a health services organization which illustrates the major principles and lessons in the chapter.
• Contains "Debate Time" sections that pose a controversial issue or present divergent perspectives to stimulate your students' thinking.
• Includes excellent coverage of theory that is thorough, clear and evidence-based.

New to this edition

• A new introductory chapter provides an overall perspective on the health care sector and the distinctive challenges facing health care organizations.
• Six new chapters focusing on: quality improvement, strategic thinking, health policy and regulation, health information technology, consumerism and ethics, and global health and health care management.
• Updated chapters covering organization, work design, and coordination; power and politics, conflict management, and negotiation; leadership and management; communication; and innovation and learning.
• Contained in each chapter is a brief case study, with questions designed to stimulate discussion among your students and encourage them to apply the concepts and principles they learn to practical managerial and organizational issues.

About the Author

• Lawton Robert Burns, is the James Joo-Jin Kim Professor, and Professor of Health Care Management in the Health Care Management Department at the Wharton School, University of Pennsylvania. He is also Director of the Wharton Center for Health Management and Economics. His research focuses on hospital-physician relationships, strategic change, integrated health care, supply chain management, health care management, formal organizations, physician networks and physician practice management firms. Dr. Burns is the author of, and contributor to several books, as well as numerous articles, on Health Care Management. He is the recipient of numerous grants, awards and Fellowships and has held many academic positions throughout his career. Dr. Burns has also provided expert witness testimony for the federal government as well as for the private sector. He is a member of the Academy of Management, the American Hospital Association and the Association for Health Services Research. Lawton R. Burns has a Bachelor of Arts Degree in Sociology and Anthropology, a Master's Degree in Sociology and a Doctor of Philosophy Degree in Sociology.
• Elizabeth H. Bradley, Ph.D. is a Professor of Epidemiology and Public Health at the Yale School of Public Health, where she directs the Health Management Program and Global Health Concentration. She is also the Director of the Yale Global Health Initiative. She has extensive academic and research experience in the public health arena and is the recipient of numerous honors and research grants. Her research focuses on health services, with an emphasis on management and quality improvement. Dr. Bradley is a member of the Gerontological Society of America, the Academy of Health, and the Association of University Programs in Health Administration. She is a faculty Associate of the American College of Healthcare Executives and a full member of the Yale Cancer Center Prevention/Control Program. She is also the author of over one hundred published papers and the author of, and contributor to, numerous books and articles in the health field. Elizabeth Howe Bradley has a Bachelor of Arts Degree in Economics, A master of Business Administration and a Doctor of Philosophy Degree in Health Policy and Health Economics.
• Bryan J. Weiner is Professor, Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill. He is the author of, and the contributor to, numerous books and articles. He is a member of the Academy of Health, the Academy of Management, the American Public Health Association and the Society for Behavioral Medicine. Dr. Weiner has a Bachelor of Arts Degree in Psychology, a Master of Arts Degree in Organizational Psychology and a Doctor of Philosophy Degree in Organizational Psychology.

Product Details

• Hardcover: 496 pages
• Publisher: Delmar Cengage Learning; 6 edition (January 21, 2011)
• Language: English
• ISBN-10: 1435488180
• ISBN-13: 978-1435488182
• Product Dimensions: 9.2 x 8.2 x 1 inches

List Price: $162.95

Barsukiewicz: The U.S. Health System: Origins & Functions 6th Edition

The U.S. Health System: Origins and Functions 6th Edition offers both a historical and current perspective of the delivery of health care in the United States. Readers will learn about the origins of our health system, the forces that have influenced its change, and how the system has responded to those forces of change to become what it is today. Key topics include costs, financing and access to health care, as well as a look at the various systems for delivering health care. Reform efforts are also discussed and new chapters on information management systems, health status and health care utilization, and public health have been introduced. Each chapter poses topics for further debate in a Question of Ethics and provides hands-on exercises in the Activity-Based Learning sections. Exhibits in each chapter will stimulate discussion on the various chapter topics.

Contents 

• 1. Introduction.
• 2. Health Care Costs.
• 3. Paying for Health Care Services.
• 4. Health Status and Health Care Utilization.
• 5. Medical Education.
• 6. Professions in Health Care.
• 7. Ambulatory Care.
• 8. Hospitals.
• 9. Mental Health Services.
• 10. Long-Term Care.
• 11. Public Health – The Health of the Community.
• 12. Information Management Systems.
• 13. Current Issues in Health Care Delivery.

Key Features

• Provides both a historical and current view of the delivery of health care in the United States.
• The book is organized into three primary sections on health care system origins, influences, and changes.
• Includes stories of real health care organizations dealing with delivery and financing of health care.
• Discusses ethical implications of health care delivery.

New to this edition

• New chapter on Public Health – The Health of the Community.
• New chapter on Technology Development and Information Management Systems.
• New chapter on Health Status and Health Care Utilization.
• New chapter on Health Status and Health Care Utilization.
• Updated Activity-Based Learning questions and Question of Ethics sections challenge students' critical thinking skills.
• Updated references with related web resources provide additional research opportunities.

About the Author

• Camille K. Barsukiewicz, Ph.D., School of Urban Affairs and Public Policy, University of Memphis, Memphis, Tennessee.
• Marshall W. Raffel, Ph.D., Professor Emeritus of Health Policy and Administration, The Pennsylvania State University, University Park, Pennsylvania.

Product Details

• Hardcover: 248 pages
• Publisher: Delmar Cengage Learning; 6 edition (January 1, 2011)
• Language: English
• ISBN-10: 1418052981
• ISBN-13: 978-1418052980
• Product Dimensions: 9.3 x 8 x 0.7 inches

List Price: $155.95 

 

McEwen: Manual of Smoking Cessation: A Guide for Counsellors & Practitioners

The smoking cessation field has undergone rapid growth over the last few years and there is now an extensive group of health care professionals from many different backgrounds who have become involved in this area. Smoking cessation is an important issue and there is ever increasing pressure to treat more smokers more effectively.

New advances in service development and in research into treating smokers are now regularly being reported in addition to the wealth of experience being gained by smoking cessation services and clinicians from around the UK. The Manual of Smoking Cessation: A guide for counsellors and practitioners expertly synthesises the evidence base with current good practice to produce detailed advice on how best to help smokers to quit.

The manual aims to provide facts, figures, suggested interventions and sources of further information to assist you in providing evidencebased treatment for smokers wishing to stop. This manual covers the core content areas and key learning outcomes described in the Standard for training in smoking cessation treatments published by the Health Development Agency in 2003.

The book is divided into two parts and six chapters:

Part One: Essential Information

• Chapter 1 ‘Smoking demographics’ looks at the prevalence and patterns of smoking and smoking cessation.
• Chapter 2 ‘The health risks of smoking and the benefits of stopping’.

Part Two: Practical Advice

• Chapter 3 ‘Brief interventions’ gives information to help you assess and record smoking status, advise smokers to stop and assess their interest in quitting. This chapter also covers nicotine dependence, compensatory smoking and onward referral.
• Chapter 4 ‘Intensive one-to-one support’ gives you the knowledge needed to provide intensive one-to-one behavioural support. It covers assessing nicotine dependence and motivation to quit, plus smoking cessation treatments, their outcomes and medications available to help with stopping smoking.
• Chapter 5 ‘Telephone counselling’.
• Chapter 6 ‘Group interventions’ provides information needed to carry out group interventions with smokers. This chapter covers the content of group treatment, the means of providing it and managing group processes.

This manual is not intended as a substitute for obtaining training and experience in smoking cessation. It is designed to complement any training that you receive and to encourage you to maximise the experience that you can gain from working with smokers wanting to stop.

Contents

• About the authors

Part One: Essential Information

1 Smoking demographics

• 1.1 Smoking patterns
• 1.2 Smoking cessation
• 1.3 Sources for updating prevalence statistics
• 1.4 Multiple choice questions

2 The health risks of smoking and the benefits of stopping

• 2.1 Smoking mortality
• 2.2 Smoking morbidity
• 2.3 Health benefits of smoking cessation
• 2.4 Sources for updating health information and statistics
• 2.5 Multiple choice questions

Part Two: Practical Advice

3 Brief interventions

• 3.1 Assessment and recording of smoking status
• 3.2 Advising smokers to stop and assessing interest in quitting
• 3.3 Compensatory smoking
• 3.4 Reasons why stopping smoking can be difficult
• 3.5 Treatment to help with stopping smoking
• 3.6 Referral to local services
• 3.7 Wider context
• 3.8 Multiple choice questions

4 Intensive one-to-one support and advice

• 4.1 Smoking cessation treatments and their outcome
• 4.2 Assessment
• 4.3 Pharmacotherapy
• 4.4 Behavioural support – withdrawal oriented treatment
• 4.5 Monitoring
• 4.6 Multiple choice questions

5 Telephone counselling

• 5.1 Recruiting smokers into treatment by telephone
• 5.2 Behavioural support by telephone
• 5.3 Multiple choice questions

6 Group interventions

• 6.1 Recruitment and assessment
• 6.2 Treatment programme for groups
• 6.3 Group treatment content
• 6.4 Monitoring and follow-up
• 6.5 Multiple choice questions

Answers to multiple choice questions

Appendices

• Appendix 1 Bupropion (Zyban) – special patient groups
• Appendix 2 Bupropion (Zyban) – drug interactions
• Appendix 3 Effect of tobacco abstinence on metabolism of some drugs
• Appendix 4 Resources
• Appendix 5 Examples of what to say when intervening with smoking clients

Index

About the authors

• Andy McEwen is Senior Research Nurse at the Cancer Research UK Health Behaviour Unit at University College London. His current research includes surveys of smokers and health professionals, pharmacokinetic studies on nicotine delivery systems and clinical trials of behavioural treatments. He also retains an interest in nursing research. In 1997, he began his clinical and academic career in smoking cessation with Robert West. In 2003, he took up his current post and is Director of the Smoking Cessation Services Research Network (SCSRN) and Programme Director of the UK National Smoking Cessation Conference (UKNSCC).
• Peter Hajek is Professor of Clinical Psychology, Head of Psychology, and Director of Tobacco Dependence Research Unit at Bart’s and the London, Queen Mary’s School of Medicine and Dentistry, University of London. His research is concerned primarily with understanding smoking behaviour and developing and evaluating smoking cessation treatments. He has authored or co-authored over 200 publications, holds various academic and editorial appointments and had input into the UK Government’s initiative to establish smoking cessation services. His unit is involved in examining both behavioural and pharmacological interventions, and in offering treatment to dependent smokers who seek help.
• Hayden McRobbie is a Research Fellow at the Clinical Trials Research Unit, University of Auckland, New Zealand, where he specialises in smoking cessation research and treatment. He studied medicine at the University of Otago and after several years in clinical medicine he moved to London to work with Professor Peter Hajek. He worked on a large number of projects and clinical trials looking at ways to help people stop smoking, as well as pharmacological and behavioural methods that alleviate the symptoms of tobacco withdrawal. In New Zealand, Hayden continues his research into treatment to help people stop smoking and retains close links with the UK, where he is a visiting lecturer at Bart’s and the London, Queen Mary’s School of Medicine and Dentistry and Programme Director of the UK National Smoking Cessation Conference.
• Robert West is Director of Tobacco Studies at the Cancer Research UK Health Behaviour Unit at University College London. He has been researching tobacco and nicotine dependence since 1982 and has published more than 250 scientific works. His research involves surveys of smoking patterns, clinical trials of aids to smoking cessation and laboratory studies of nicotine withdrawal symptoms. He is co-author of the English National Smoking Cessation Guidelines that provided the blueprint for the English Stop Smoking Services and is also Editor-in-Chief of the journal Addiction.

Product Details

• Paperback: 160 pages
• Publisher: Wiley-Blackwell; 1 edition (July 10, 2006)
• Language: English
• ISBN-10: 1405133376
• ISBN-13: 978-1405133371
• Product Dimensions: 6.8 x 0.4 x 9.6 inches

List Price: $52.99 

 

Antibiotic Resistance: Understanding and Responding to an Emerging Crisis

Recent human activities have profoundly influenced our global environment, often in ways we did not anticipate. An example is our use of antibiotics. Initially hailed as “magic bullets,” these chemical agents are now used so often that success threatens their long-term utility. Unfortunately, the natural mutability of microbes enables pathogens to develop bullet-proof shields that make antibiotic treatments increasingly ineffective. Our failure to adequately address resistance problems may ultimately push the control of infectious disease back to the pre-penicillin era. Indeed, it is now impractical to simply invent additional antibiotics to replace those lost to resistance. However, ideas have emerged for slowing the development of antibiotic resistance in individual patients and in the human population as a whole. "Antibiotic Resistance" introduces these ideas.

"Antibiotic Resistance" was initially drafted to supplement studies of infectious disease. The problem of resistance tends to be neglected, which puts the well-being of our society at increasing peril. In the course of completing this book, we realized that everyone makes decisions about antibiotic use; therefore, everyone needs to understand how human activities contribute to resistance. Individual patients, medical providers, and agricultural specialists all have a role to play in providing a safer environment. We now aim to make the principles of antibiotic use and effectiveness available to a large audience: farmers, hospital administrators, government regulators, health department personnel, pharmaceutical executives, and especially individual users. (Individual patients pressure their doctors for treatments, and in most cases, patients decide whether to take medicines as prescribed; in countries where prescriptions are not required to purchase antibiotics, patients are major decision makers.) Such diversity in readership poses a challenge.

Fortunately, detailed descriptions of chemical structures, molecular mechanisms, and epidemiological modeling are not required to understand the principles of resistance. We focus on broad concepts supported by examples and descriptions of key experiments. We expect that "Antibiotic Resistance" will be a quick read for persons with knowledge of biology. Those readers can then build on the principles with follow-up reading. Lay readers may find that some terms need to be defined. For them, we have provided a glossary and appendixes covering background concepts.

Our goal with "Antibiotic Resistance" is to point out how human activities contribute to the problem of resistance. Our hope is that an understanding of the complex factors involved in resistance will lead to changes that lengthen antibiotic life spans. An example of the complexity is seen in the traditional practice of setting antibiotic doses only high enough to cure disease. We argue that this practice encourages the emergence of resistance, that more stringent antibiotic regimens are needed to preempt the emergence of resistance. But from an individual patient perspective, using higher doses seems excessive when milder treatment usually cures disease. Why should the individual patient risk toxic side effects to preserve antibiotics for the general population? Antibiotic waste disposal problems are also complex. In principle, environmental contamination with antibiotics exerts selective pressure on microbes. That pressure can lead to the evolution of resistance genes that then spread from one organism to another and eventually reach human pathogens. We do not know how often this scenario occurs, whether it is reversible, or how much we need to improve agricultural and hospital disposal programs to stop the process.

- The Authors -

Contents

Chapter 1 Introduction to the Resistance Problem

• MRSA Is Putting Resistance in the News
• Humans Live with Many Pathogens
• Antibiotics Block Growth and Kill Pathogens
• Broad-Spectrum Antibiotics Also Perturb Our Microbiomes
• Antibiotic Resistance Protects Pathogens
• Antibiotic Resistance Is Widespread
• Antibiotic Resistance Is Divided into Three Types
• The Development of New Antibiotics Is Slowing
• Vaccines Block Disease
• Perspective

Chapter 2 Working with Pathogens

• Pathogens Are a Diverse Group of Life Forms
• Pathogen Numbers Are Measured by Microscopy and by Detecting Growth
• Molecular Probes Can Be Specific and Highly Sensitive
• Koch’s Postulates Help Establish That a Pathogen Causes Disease
• Modern Biology Has Refined Koch’s Postulates
• Pathogen Studies Focus on Populations

Chapter 3 A Survey of Antibiotics

• Antibiotics Are Selective Poisons
• Antibiotics Are Found in a Variety of Ways
• Antibacterial Agents Usually Attack Specific Targets
• Antibacterial Agents May Have a Generalized Effect
• Most Antifungal Agents Attack Membranes and Cell Walls
• Antiprotozoan Agents Tend to Be Disease-Specific Antihelminth Agents Are Used with a Wide Variety of Worms .
• Antiviral Agents Are Often Narrow Spectrum
• Human Immunodeficiency Virus (HIV)
• Influenza Virus
• Herpes Virus
• Antibiotic Classes Evolve
• Antiseptics and Disinfectants Decontaminate Surfaces

Chapter 4 Dosing to Cure

• Treatment Strategies Have Been Determined Empirically
• Susceptibility Testing Guides Antibiotic Choice
• Testing for Viruses Bypasses Pathogen Growth
• PK/PD Indices Help Determine Antibiotic Dosage
• Young Children Are Not Little Adults
• Toxic Side Effects Are Determined Empirically
• Duration of Treatment Is Determined Empirically
• Prophylaxis Preempts Disease
• Management Programs Control Hospital Antibiotic Policy
• Self-Medication Is Outside the Guidelines

Chapter 5 Emergence of Resistance

• Resistance Can Emerge in Individual Patients
• Spontaneous Mutations Are Nucleotide Sequence Changes
• Emergence of Spontaneous Resistance Often Arises Stepwise
• Mutant Selection Window Hypothesis Describes Emergence of Spontaneous Resistance
• Mutations Can Be Caused (Induced) by Antibiotic Treatment
• Resistance Arises from Several Molecular Mechanisms
• Treatment Time Can Contribute to Resistance
• Mutator Mutations Increase Mutation Frequency
• Phenotypic Resistance Occurs Without Mutations
• Resistance May Compromise Antiseptic and Disinfectant Use
• Viral Resistance Can Arise Readily
• Resistance Mutations Can Affect Pathogen Fitness
• Unintended Damage Can Arise from Treatment

Chapter 6 Movement of Resistance Genes Among Pathogens

• Horizontal Gene Transfer Involves Specific Molecular Events
• Recombination Involves Breaking and Rejoining of DNA Molecules
• Plasmids Are Molecular Parasites
• Some Plasmids Move by Conjugation
• Bacteriophages Move Bacterial Genes by Transduction
• Bacterial Transformation Involves Uptake of DNA from the Environment
• Transposition Moves Genes from One DNA to Another
• Gene Mobilization Moves Genes from the Chromosome to a Plasmid
• Integrons Gather Genes into an Expression Site
• Genomic Islands Help Create Pathogens
• Plasmid Enzymes Can Be Inhibited

Chapter 7 Transmission of Resistant Disease

• Spread of Pathogens Is Highly Evolved
• Infection Control as Local Crisis Management
• Tuberculosis Is Airborne
• Airborne Viruses
• Digestive-Tract Pathogens
• Direct-Contact Pathogens
• Arthropod-Borne Pathogens
• Blood-Borne Infections
• Multiple-Mode Transmission

Chapter 8 Surveillance

• Surveillance Is the First Line of Defense
• The Denominator Effect Lowers Surveillance Accuracy
• Surveillance Consortia Collect and Process Data
• Molecular Methods Provide Rapid Pathogen Identification
• Interpretation of Surveillance Studies
• Surveillance Indicates Resistance Problems with Gonorrhea
• Policy Changes Are Occurring in Agricultural Practice

Chapter 9 Making New Antibiotics

• New Antibiotics Are Temporary Solutions
• Model Systems Are Used to Speed Drug Discovery
• Natural Products Are a Source of Antibiotics
• High-Throughput Screening Accelerates Antibiotic Discovery
• Rational Drug Design Can Identify Antibiotics
• New Antibiotics Must Have Few Side Effects
• Antibiotic Discovery Faces a Fundamental Economic Problem

Chapter 10 Restricting Antibiotic Use and Optimizing Dosing

• Antibiotic Conservation: Use Less Often When Unnecessary and Higher Amounts When Needed
• Human Consumption of Antibiotics Correlates with Resistance
• Limiting Human Consumption of Antibiotics
• Agricultural Use Contributes to Antibiotic Consumption
• Antibiotic Contamination of the Environment Is a Byproduct of Usage
• Clinical Resistance and Resistant Mutants Are Not the Same
• Dosing to Eradicate Susceptible Cells May Not Halt Emergence of Resistance Keeping Concentrations Above MPC Restricts Mutant Amplification
• Combining MPC with PK/PD Targets
• Combination Therapy Restricts Emergence of Resistance
• Consideration of Resistance During Drug Discovery

Chapter 11 Influenza and Antibiotic Resistance

• Seasonal Influenza Virus Is Controlled by Vaccines
• Antiviral Resistance Has Emerged Among Seasonal Influenza Virus
• Pandemic Influenza Can Be a Killer
• Avian Flu H5N1 Is a Candidate for Deadly Pandemic Flu
• Antibiotics May Play an Important Role in Pandemic Influenza
• Antibiotic Resistance Occurs with Avian Flu H5N1
• Bacterial Pneumonia May Create Another Resistance Problem

Chapter 12 Avoiding Resistant Pathogens

• Consumer Perspective Differs from That of Public Health Official or Manufacturer
• Avoiding Airborne Infection Is Difficult
• Precautions Can Be Taken with MRSA
• Sexually Transmitted Infections Require Renewed Attention
• Arthropod-Borne Infections Are on the Move
• Contaminated Food Is Common
• Avoid Rounds of Treatment Interspersed with Pathogen Outgrowth
• Consume Only with Sound Indications, Choose Optimal Antibiotics
• Afterword A Course of Action
• Overuse
• Dosing
• Drug Discovery and Surveillance
• Resistance as a Side Effect

Appendix A Molecules of Life

• The Action of Molecules Defines Life
• Proteins Are Molecular Workers
• DNA Is the Repository of Genetic Information
• RNA Plays Several Roles in Life Processes
• Carbohydrates Store Energy, Form Cell Walls, and Make Rigid Structures
• Lipids Store Energy and Form Membranes
• Cellular Chemistry Is Organized into Metabolic Pathways

Appendix B Microbial Life Forms

• Bacteria Lack Nuclei and Other Organelles
• Fungi Are Eukaryotes Having Cell Walls But Not Chloropasts
• Parasitic Protozoa Are Eukaryotes Lacking a Cell Wall
• Helminths Are Parasitic Worms
• Viruses Are Inert Until They Infect
• Glossary
• Literature Cited
• Index

About the Authors

• Karl Drlica, Ph.D. is a Principal Investigator at the Public Health Research Institute and Professor of Microbiology & Molecular Genetics at the UMDNJ—New Jersey Medical School in Newark, New Jersey. Dr. Drlica’s laboratory focuses on fluoroquinolone action and resistance with Mycobacteriun tuberculosis and other bacteria, including approaches for slowing the enrichment and amplification of resistant bacterial subpopulations.
• David S. Perlin, Ph.D. is Executive Director of the Public Health Research Institute and UMDNJ Regional Biocontainment Laboratory, as well as Professor of Microbiology & Molecular Genetics at the New Jersey Medical School in Newark, New Jersey. He is also a Fellow of the New York Academy of Sciences. Dr. Perlin’s laboratory explores mechanisms of antifungal drug resistance, rapid detection of drug-resistant bloodstream pathogens in high-risk patients, and the application of small animal models for the study of respiratory pathogens.

 

Product Details

• Hardcover: 288 pages
• Publisher: FT Press; 1 edition (2011)
• Language: English
• ISBN-10: 0131387731
• ISBN-13: 978-0131387737
• Product Dimensions: 10 x 7.1 x 1 inches

List Price: $49.99 

 

Porta: A Dictionary of Epidemiology 5th Edition

If you live in a foreign land and have come to visit this book from "outside" epidemiology, be welcome. If you are an epidemiologist on the eve of a "trip" to a foreign discipline, please take this book with you. And, again, if you mostly work "inside" epidemiology, please keep it at hand: this is your territory - yet I hope you will here discover new landscapes of unsuspected beauty.

- Miquel Porta -

Key Features

• Alphabetical Listing, is a guide to the placement of entries and follows a letter-by-letter sequence of headwords without regard to word spacing, hyphens, or apostrophes.
• Headwords, are in bold small capitals.
• Compound Phrases.
• Citations, have been moved to the back of the book to avoid repetition.
• Acronyms.
• Cross-References.
• Definitions and Discussions.
• Evolving Language and Changing Usage.

About the Editors

• Miquel Porta, Professor of Preventive Medicine & Public Health, School of Medicine, Universitat Autònoma de Barcelona; Senior Scientist, Institut Municipal d’Investigació Mèdica, Barcelona, Spain; Adjunct Professor of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill.

Foreword

To write a dictionary in any scientific discipline is a risky endeavor, because scientists often disagree. The nature of science is not to reach consensus but to advance our knowledge by bringing confl icting ideas to critical examinations. That is true also for how we define the concepts we use. No dictionary will ever be able to satisfy all, nor should it try to.

The aim of the International Epidemiological Association (IEA) in cosponsoring this dictionary in its more than 20 years’ history has been to facilitate communication among epidemiologists to develop a "common language" to the extent that this is possible. We need a common language when we write papers, teach, and communicate findings to the public.

This "common language" changes over time, as anybody can see by reading the successive editions of this dictionary. The language changes because our understanding of the concepts changes over time and new research options bring forward new concepts.

From the IEA, we want to thank John Last for his tremendous achievements as editor of the dictionary, and we are happy to welcome Miquel Porta as the new editor. Miquel has provided the smooth transition we were looking for, and we are pleased to see that he continues the tradition of collaborating with leading epidemiologists worldwide to get the best possible result.

- Jørn Olsen, Neil Pearce, and Chitr Sitthi-Amorn -

Current, coming, and past presidents of International Epidemiological Association (www.ieaweb.org)

Product Details

• Paperback: 320 pages
• Publisher: Oxford University Press, USA; 5 edition (July 3, 2008)
• Language: English
• ISBN-10: 0195314506
• ISBN-13: 978-0195314502
• Product Dimensions: 9.1 x 6.1 x 0.9 inches

List Price: $29.95 

 

Delivering Health Care In America: A Systems Approach 5th Edition

Given the recent and rapid developments in the delivery of health care in the United States, never has it been more important to have the most up-to-date resources for teaching students about this complex and dynamic industry. Now in its Fifth Edition, Delivering Health Care in America offers the most current and comprehensive overview of the basic structures and operations of the U.S. health system--from its historical origins and resources, to its individual services, cost, and quality. Using a unique “systems” approach, this bestselling text brings together an extraordinary breadth of information into a highly accessible, easy-to-read resource that clarifies the complexities of health care organization and finance, while presenting a solid overview of how the various components fit together.

New to this Edition

• New material on U.S. health reform
• New material on health reform in other countries
• New material on Healthy People 2020
• New information on CMS’s innovative healthcare delivery
• New information on community health centers
• Introduction of the medical home concept
• Data update throughout the book
• Latest research findings as applicable
• Enhanced content on The Patient Protection and Affordability Act of 2010
• Enhanced content on clinical guidelines
• Enhanced content on public health system and services
• Enhanced content on vulnerable populations
• Enhanced content on primary care from the
• Global Perspective
• Revised perspectives on the future of health care in America

Contents

• Chapter 1 A Distinctive System of Health Care Delivery

Part I System Foundations

• Chapter 2 Beliefs,Values, and Health
• Chapter 3 The Evolution of Health Services in the United States

Part II System Resources

• Chapter 4 Health Services Professionals
• Chapter 5 Medical Technology
• Chapter 6 Health Services Financing

Part III System Processes

• Chapter 7 Outpatient and Primary Care Services
• Chapter 8 Inpatient Facilities and Services
• Chapter 9 Managed Care and Integrated Organizations
• Chapter 10 Long-Term Care
• Chapter 11 Health Services for Special Populations

Part IV System Outcomes

• Chapter 12 Cost, Access, and Quality
• Chapter 13 Health Policy

Part V System Outlook

• Chapter 14 The Future of Health Services Delivery

About the Authors

• Leiyu Shi, DrPH, MBA, MPA, is an Associate Professor in the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, and Co-Director of Johns Hopkins Primary Care Policy Center for the Underserved Populations. Dr. Shi's research focuses on primary care, health disparities, and vulnerable populations. He has conducted extensive studies about the association between primary care and health outcomes, particularly on the role of primary care in mediating the adverse impact of income inequality on health outcomes. Dr. Shi is also well known for his extensive research on the nation's vulnerable populations, in particular community health centers that serve vulnerable populations, including their sustainability, provider recruitment and retention experiences, financial performance, experience under managed care, and quality of care. Dr. Shi is the author of three textbooks and nearly 100 journal articles.
• Douglas A. Singh, PhD, MBA, Associate Professor of Management, School of Business and Economics, Indiana University at South Bend, teaches graduate and undergraduate courses in health care delivery, policy, finance, and management in the School of Business and Economics and in the Department of Political Science at Indiana University-South Bend. He has authored/coauthored four books and has published in peer-reviewed journals. Before pursuing an academic career, he spent over 15 years in the long-term care industry and held positions of administrator, regional manager, vice president, and consultant. He was awarded the long-term care research award by the Foundation of American College of Health Care Administrators in 1995.

Product Details

• Paperback: 638 pages
• Publisher: Jones & Bartlett Learning; 5 edition (2011)
• Language: English
• ISBN-10: 1449626505
• ISBN-13: 978-1449626501
• Product Dimensions: 10 x 6.9 x 1.5 inches 

List Price: $99.95 

 

McKenzie: An Introduction to Community Health 7th Edition

An Introduction to Community Health, Seventh Edition, has been updated to reflect the latest trends and statistics in community health. With an emphasis on developing the knowledge and skills necessary for a career in health education, this best-selling introductory text covers such topics as epidemiology, community organization, program planning, minority health, health care, mental health, environmental health, drugs, safety, and occupational health. Short scenarios, key terminology, marginal definitions, and web activities are included in each chapter to make this an accessible and reader-friendly resource for the beginning community health student.

Key Features

• Each chapter includes a short scenario that helps students relate chapter content to their everyday lives, identifies key ideas in the chapter, and highlights learning objectives.
• Key terms are placed in boldfaced type and defined both in the margins of the text and in the glossary.
• Web activities encourage students to further explore content by visiting relevant community/public health websites.
• Suggested activities help students apply what they have learned in the text or research it further.

Contents

Unit 1 Foundations of Community Health

• Chapter 1 Community Health: Yesterday, Today, and Tomorrow
• Chapter 2 Organizations That Help Shape Community Health
• Chapter 3 Epidemiology: The Study of Disease, Injury, and Death in the Community
• Chapter 4 Epidemiology: Prevention and Control of Diseases and Health Conditions
• Chapter 5 Community Organizing/Building and Health Promotion Programming
• Chapter 6 The School Health Program: A Component of Community Health

Unit 2 The Nation’s Health

• Chapter 7 Maternal, Infant, and Child Health
• Chapter 8 Adolescents, Young Adults, and Adults
• Chapter 9 Elders
• Chapter 10 Community Health and Minorities
• Chapter 11 Community Mental Health
• Chapter 12 Alcohol, Tobacco, and Other Drugs: A Community Concern
• Chapter 13 Health Care System

Unit 3 Environmental Health and Safety

• Chapter 14 Community Health and the Environment
• Chapter 15 Injuries as a Community Health Problem
• Chapter 16 Safety and Health in the Workplace

About the Authors

James F. McKenzie, PhD, MPH, CHES-Professor Emeritus, Ball State University

Jim McKenzie, Professor in the Department of Physiology and Health Science at Ball State University, earned his PhD from The Ohio State University, and a MPH from the University of Michigan. He has also served on the faculties at Bowling Green State University and Mankato State University. He is a certified health education specialist (CHES) and currently serves on NCHEC's Division Board for Certification of Health Education Specialists. He is co-author of four textbooks: Planning, Implementing, and Evaluating Health Promotion Programs: A Primer (5th ed., in press, Benjamin Cummings), Introduction to Community Health (6th ed., in press, Jones & Bartlett Publishers), Principles and Foundations of Health Promotion and Education (4th ed., in press, Benjamin Cummings), and Research Methods in Health Promotion and Education (1st ed., 2005, Jones & Bartlett). He is a member of Society of Public Health Education, American Association for Health Education, American School Health Association, Eta Sigma Gamma, and the North American Primary Care Research Group.

Robert R. Pinger, PhD-Professor Emeritus, Ball State University

Robert R. Pinger is a Professor in the Department of Physiology and Health Science at Ball State University and has been the Director of the Department’s Public Health Entomology Laboratory since 1977. He earned his MS and PhD from Iowa State University and completed postdoctoral training in medical entomology at the Walter Reed Army Institute of Research. He has taught at the Federal University of Amazonas, Manaus, Brazil and Yeungnam University, Daegu, Republic of Korea. He is co-author of two textbooks: Drugs: Issues for Today (3rd ed., McGraw-Hill) and Introduction to Community Health (6th ed., in press, Jones & Bartlett Publishers) and more than 25 scientific articles. He is a member of American Public Health Association, the Entomological Society of America and Sigma Xi, the Research Society of America.

Jerome E. Kotecki, HSD-Ball State University

Jerome E. Kotecki is a Professor of Health Science in the Department of Physiology and Health Science at Ball State University. Dr. Kotecki earned his doctorate in health science and his masters’ degree in exercise science from Indiana University. Professor Kotecki has published over 30 scientific articles and is co-author of the best selling textbooks An Introduction to Community Health and Physical Activity and Health: An Interactive Approach. Dr. Kotecki’s current research is focused on the impact of lifestyle medicine on chronic diseases. He is the lead scientist on several large healthy lifestyle studies focusing on the role of health-care professionals in health counseling.

Product Details

• Paperback: 616 pages
• Publisher: Jones & Bartlett Learning; 7 edition (2011)
• Language: English
• ISBN-10: 0763790117
• ISBN-13: 978-0763790110
• Product Dimensions: 9.8 x 8 x 1.3 inches

List Price: $119.95 

 

Skolnik: Global Health 101 2nd Edition

Global Health 101, Second Edition (formerly titled Essentials of Global Health) is a clear, concise, and user-friendly introduction to the most critical issues in global health. It illustrates key themes with an extensive set of case studies, examples, and the latest evidence. While the book offers a global perspective, particular attention is given to the health-development link, to developing countries, and to the health needs of poor and disadvantaged people. Global Health 101 builds on the success of an introductory global health course taught by the author at the George Washington School of Public Health and Health Services and is ideally suited for the Association of American Colleges and Universities recommended course by the same name.

Richard Skolnik is the winner of numerous honors for teaching, has taught global health for 8 years, and has more than 30 years of experience as a global health practitioner in multilateral, university, and NGO settings. He has been actively involved in dealing with critical issues in global health at country level and at the highest levels of international health policy making. Learn more about the author.

The book is organized in four parts:

• Principles, Measurements, and the Health-Development Link: The principles of Global Health; Health Determinants, Measurements, and Trends; and Health, Education, Poverty, and the Economy.
• Cross-Cutting Global Health Themes: Human Rights, Ethics, and Global Health; An Introduction to Health Systems; and Culture and Health.
• The Burden of Disease: The Environment and Health; Nutrition and Health; Women’s Health; Child Health; Infectious Diseases; Non-Communicable Diseases; and Unintentional Injuries.
• Working Together to Improve Global Health: Conflicts, Natural Disasters, and Other Emergencies; Cooperating to Improve Global Health; and, Science Technology, and the Public’s Health.”

Updates to the Second Edition

• The most recent data on the burden of diseases of importance and updated tables and charts with the most recent projections of the future burden of disease
• An expanded section on health disparities and health equity
• A greatly expanded section on Neglected Tropical Diseases
• Expanded sections on the financing of global health and innovative financing mechanisms
• A new section on drug resistance and emerging and re-emerging infectious diseases
• Additional information on innovative mechanisms for program implementation in areas related to key chapter topics, such as performance-based financing.
• An expanded section on public-private partnerships and product development partnerships for health
• About 30 briefs on policies and programs illustrating the main chapter themes
• A NEW chapter, “Working in Global Health”, which details the many career opportunities in the field.
• A NEW chapter "Profiles of Global Health Actors" that offers informative and inspiring profiles of 18 global health actors, from women who lead grassroots organizations for HIV positive women in Africa to senior staff of major international organizations.
• A completely revised chapter on ethics in global health, highlighting key ethical concepts to be considered in global health efforts
• An expanded chapter on non-communicable diseases including new and expanded sections on demography and health and vital registration
• A NEW section on on health and equity
• Substantially expanded information on the key irganizational actors in global health.

Table of Contents

Part 1 Principles, Measurements, and the Health-Development Link

• Chapter 1 The Principles and Goals of Global Health
• Chapter 2 Health Determinants, Measurements, and Trends
• Chapter 3 Health, Education, Poverty, and the Economy

Part II Cross-Cutting Global Health Themes

• Chapter 4 Ethical and Human Rights Concerns in Global Health
• Chapter 5 An Introduction to Health Systems
• Chapter 6 Culture and Health

Part III The Burden of Disease

• Chapter 7 The Environment and Health
• Chapter 8 Nutrition and Global Health
• Chapter 9 Women’s Health
• Chapter 10 Child Health
• Chapter 11 Communicable Diseases
• Chapter 12 Non-Communicable Diseases
• Chapter 13 Unintentional Injuries

Part IV Working Together to Improve Global Health

• Chapter 14 Natural Disasters and Complex Humanitarian Emergencies
• Chapter 15 Working Together to Improve Global Health
• Chapter 16 Science, Technology, and Global Health
• Chapter 17 Working in Global Health
• Chapter 18 Profiles of Global Health Actors

About the Author

• Richard Skolnik, MPA is a half-time Lecturer in Global Health at The George Washington University (GWU) where he teaches two undergraduate courses each term in global health and development and supervises graduate student Master of Public Health (MPH) projects. Richard also works as an independent consultant on program design and evaluation activities in a number of areas of global health, including HIV, TB, and nutrition.

Book Reviews

“Richard Skolnik’s book is a goldmine for students who are looking for a strong foundation and practical, up-to-date information about the key aspects of the global health field. The book conceptualizes this broad field in meaningful sections, which are well researched and extremely readable. Skolnik has found the right balance between theory and practice. The selected cases give wonderful insights about real-life challenges in global health, and Skolnik’s emphasis on the unfinished agenda of alleviating poverty, enhancing equity, and improving the health of the poor in low and middle-income countries is especially welcome. This book is a must-read for undergraduate and graduate students alike who want to improve human health around the globe.”

By Elizabeth H. Bradley, PhD, Professor of Public Health, Global Health Leadership Institute, Yale University.

“This book will be useful to students who are excited about global health and who wish to channel their enthusiasm into learning. Because Richard Skolnik has spent a career converting ideas into action, a particularly strong feature of this volume is its emphasis on the relevance of global health knowledge to the practical challenges of today. This book is essential for all students of any age interested in studying, and solving, some of the major global challenges of our time.”

By Prabhat Jha, MD, DPhil, Canada Research Chair in Health and Development, Director, Centre for Global Health Research, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Dalla Lana School of Public Health, University of Toronto.

Product Details

• Paperback: 464 pages
• Publisher: Jones & Bartlett Learning; 2 edition (August 15, 2011)
• Language: English
• ISBN-10: 0763797510
• ISBN-13: 978-0763797515

List Price: $74.95

 

Buchbinder: Introduction To Health Care Management 2nd edition

Introduction to Health Care Management is a concise, reader-friendly, introductory healthcare management book that covers a wide variety of healthcare settings, from hospitals to nursing homes and clinics. Filled with examples to engage the reader’s imagination, the important issues in healthcare management, such as ethics, cost management, strategic planning and marketing, information technology, and human resources, are all thoroughly covered.

Guidelines and rubrics along with numerous case studies make this text both student-friendly and teacher friendly. It is the perfect resource for students of healthcare management, nursing, allied health, business administration, pharmacy, occupational therapy, public administration, and public health.

Key Features

• Chapters contributed by real experts using an active voice to grab the reader’s attention.
• Learning objectives and discussion questions in each chapter.
• Instructors’ resources online for each chapter, including PowerPoints, Test Bank, and Sample Syllabus.
• Case studies in a wide variety of settings, in an assortment of healthcare management topics.
• A case study guide, with rubrics for evaluation of student performance, enabling instructors at every level of experience to hit the ground running on that first day of class.

New to the Second Edition

• A new introductory chapter: “Understanding Health Care Management”
• A new chapter on Health Care Marketing
• A new discussion of healthcare planning and examples of planning models
• New contributing authors – experts in their fields
• New section on emotional intelligence
• Over seven new case studies
• Improved case study instructions
• New rubrics

Online resources now include

• Syllabus for 8-week online course
• Key discussion points for each case study
• Role play, simulation, and scripts for students
• Online video references

Contents 

• Chapter 1 An Overview of Healthcare Management
• Chapter 2 Leadership
• Chapter 3 Management and Motivation
• Chapter 4 Organizational Behavior and Management Thinking
• Chapter 5 Strategic Planning
• Chapter 6 Healthcare Marketing
• Chapter 7 Quality Improvement Basics
• Chapter 8 Information Technology
• Chapter 9 Financing Health Care and Health Insurance
• Chapter 10 Managing Costs and Revenues
• Chapter 11 Managing Healthcare Professionals
• Chapter 12 The Strategic Management of Human Resources
• Chapter 13 Teamwork
• Chapter 14 Addressing Health Disparities: Cultural Proficiency
• Chapter 15 Ethics and Law
• Chapter 16 Fraud and Abuse
• Chapter 17 Healthcare Management Case Studies and Guidelines

About the Authors

• Sharon B. Buchbinder, RN, PhD, is the former Professor and Chair of the Department of Health Science at Towson University and is now President of the American Hospital Management Group Corporation, MASA Healthcare Co, a health care management education and health care delivery organization based in Owings Mills, MD. For over three decades, Dr. Buchbinder has worked in many aspects of healthcare as a clinician, researcher, association executive, and academic. With a PhD in Public Health from the University of Illinois School of Public Health, she brings this blend of real world experience and theoretical constructs to undergraduate and graduate face to face and online classrooms, where she is constantly reminded of how important good teaching really is. She is Past Chair of the Board of the Association of University Programs in Health Administration (AUPHA) and co-author of the Bugbee-Falk Award winning, Career Opportunities in Health Care Management: Perspectives from the Field.
• Nancy H. Shanks, PhD, has extensive experience in the health care field. For 12 years she worked as a health services researcher and health policy analyst and later served as the executive director of a grant-making, fund-raising foundation that was associated with a large multihospital system in Denver. During the last 15 years Dr. Shanks has been a healthcare administration educator at Metropolitan State College of Denver, where she has taught a variety of undergraduate courses in health services management, organization, research, human resources management, strategic management, and law. She is currently a Professor in the Health Care Management Program after having served as Chair of the Department of Health Professions for 7 years. Dr. Shanks’ research interests have focused on health policy issues, such as providing access to health care for the uninsured.

Product Details

• Paperback: 498 pages
• Publisher: Jones & Bartlett Learning; 2 edition (2011)
• Language: English
• ISBN-10: 0763790869 
• ISBN-13: 978-0763790868
• Product Dimensions: 9.1 x 7 x 1.4 inches

List Price: $79.95